Daily steps and sitting time: what the curves show

A 52-year-old man shows his watch at the appointment. He hit the 10,000-step goal on just two days of the week and feels he is falling short. On the other days, he stays near 5,000, because he works sitting down from 8 a.m. to 6 p.m. He wants to know whether walking "only" 5,000 steps is worth anything and whether the hours in the chair cancel out the evening walk.

These are two good questions, and the answers have changed a lot in recent years. Watches and phones have made steps the most popular way to measure activity, and accelerometers have made it possible to run studies with tens of thousands of people followed for years. These studies produced curves that relate steps and sitting time to mortality, and they tell a more useful story than a round number.

This text shows what these curves say, where the 10,000-step goal came from, where the plateaus are, how much sitting time weighs and what precautions to take before turning an association into a recommendation. For the big picture on how to prescribe physical activity, see exercise as prescription: the WHO recommendation in practice.

Key points

• In a meta-analysis of 47,471 adults, the risk of death fell progressively with more steps, with a plateau between 6000 and 8000 steps from age 60 onward (Paluch, 2022).
• Below age 60, the plateau was between 8000 and 10,000 steps per day (Paluch, 2022).
• The 10,000-step goal probably came from the commercial name of a Japanese pedometer from 1965 (Lee, 2019).
• The studies did not find a minimum threshold: every increase from low levels was associated with lower risk (Del Pozo Cruz, 2022).
• Above 6 to 8 hours sitting per day, the risk of death rises even after accounting for physical activity (Patterson, 2018).
• Short bursts of vigorous effort in daily life are also associated with lower mortality (Stamatakis, 2022).

Summary

• Where the 10,000-step goal came from
• What a mortality curve is and how to read it
• What the large cohorts showed about steps
• Sitting time as a risk factor of its own
• Breaking up sitting time and short bursts of effort
• The limits of these studies
• How to use steps in the appointment
• How NEXO helps train this reasoning
• Frequently asked questions
• Take-home messages

Where the 10,000-step goal came from

The number has a curious origin. The authors of the study with older women from the Women's Health Study explain that it probably derives from the name of a pedometer sold in 1965 by a Japanese company, called Manpo-kei, which means "10,000-step meter" (Lee, 2019). The goal was born as a commercial brand, not as a research result.

That does not make the number wrong, but it explains why it is arbitrary. For most sedentary people, 10,000 steps is a distant goal, which can discourage someone at 3,000 or 4,000. The correct scientific question is different: how does risk change as steps increase, and from what point does the additional gain become small?

The 2020 World Health Organization guideline does not use steps as a goal. It recommends 150 to 300 minutes per week of moderate activity and stresses that some activity is better than none (Bull, 2020). Steps are a practical way to measure part of that activity, but they do not replace it, because they do not capture cycling, swimming or strength training.

What a mortality curve is and how to read it

The curves in these studies show, on the horizontal axis, the number of steps or hours sitting and, on the vertical axis, the relative risk of death compared with a reference group. They are usually built with cubic splines, a method that lets the data draw the shape of the curve instead of imposing a straight line.

Three shapes appear often. In the linear curve, each additional step brings the same gain. In the curve with a plateau, the gain is large at first and decreases until it almost stops. In the J-shaped curve, risk rises again at the extremes. For daily steps, the predominant shape is the plateau (Paluch, 2022), similar to the one described for physical activity in general, in which most of the benefit comes from the first increases (Kraus, 2019).

Reading the curve requires attention to the reference group. A hazard ratio of one half means half the risk of the comparison group, which is usually the least active quarter. If that group includes people who are bedridden or very ill, the comparison exaggerates the benefit. This issue, reverse causality, is discussed further below and is the main limitation of all these studies.

The logic is the same as for any risk estimate: the number only makes sense when you know who the person is being compared with, just as the interpretation of a test depends on the pretest probability.

What the large cohorts showed about steps

The meta-analysis of 15 cohorts

The most cited study pooled individual data from 15 international cohorts, with 47,471 adults and 3013 deaths over a median follow-up of 7.1 years (Paluch, 2022). The median step counts in the four quarters were 3553, 5801, 7842 and 10,901 per day. Compared with the least active quarter, the hazard ratios were 0.60, 0.55 and 0.47 (Paluch, 2022).

The most useful finding for practice was the plateau by age. From age 60 onward, risk fell progressively up to about 6000 to 8000 steps per day; below age 60, up to about 8000 to 10,000 steps (Paluch, 2022). Walking speed was associated with mortality in some measures, but it lost strength when total step count entered the analysis.

American adults and older women

In the study with a representative sample of American adults aged 40 or older, 4840 people wore an accelerometer for up to seven days and were followed for about ten years (Saint-Maurice, 2020). Compared with 4000 steps per day, walking 8000 steps was associated with a hazard ratio of 0.49, and 12,000 steps with 0.35 (Saint-Maurice, 2020).

In the Women's Health Study, 16,741 women with a mean age of 72 years took an average of 5499 steps per day (Lee, 2019). The hazard ratios in the step quarters were 0.59, 0.54 and 0.42 compared with the least active (Lee, 2019). Risk fell up to about 7500 steps per day and then leveled off. Walking intensity, after adjustment for step count, lost most of its association.

Two recent meta-analyses

A meta-analysis of 17 cohorts with 226,889 people estimated that each additional 1000 steps per day was associated with a hazard ratio of 0.85 for all-cause mortality, and each additional 500 steps with 0.93 for cardiovascular mortality (Banach, 2023). The association with all-cause mortality appeared from about 3867 steps, and with cardiovascular mortality from just 2337 steps.

In the UK Biobank, 78,500 adults wore a wrist accelerometer and were followed for a median of seven years (Del Pozo Cruz, 2022). More steps were associated with lower all-cause, cardiovascular and cancer mortality up to about 10,000 steps, and also with fewer new cases of these diseases. The authors found no minimum threshold for benefit.

Study	Population	Main finding	Source
Meta-analysis of 15 cohorts	Adults from several countries	Plateau of 6000 to 8000 steps from age 60 and of 8000 to 10,000 below age 60	Paluch, 2022
American national sample	Adults aged 40 or older	8000 steps with lower risk than 4000	Saint-Maurice, 2020
Women's Health Study	Women with a mean age of 72 years	Plateau near 7500 steps	Lee, 2019
Meta-analysis of 17 cohorts	People who are healthy or at cardiovascular risk	Each additional 1000 steps with lower risk	Banach, 2023
UK Biobank	Adults aged 40 to 79	Benefit from low levels up to near 10,000	Del Pozo Cruz, 2022
Meta-analysis of sitting time	More than one million people	Higher risk above 6 to 8 hours sitting	Patterson, 2018

What the curves say together

The studies agree on three points. The first is that the greatest gain is in moving out of the lowest levels: going from 3 or 4 thousand to 6 or 7 thousand steps corresponds to the steepest part of the curve (Paluch, 2022; Banach, 2023). The second is that a plateau exists, and it appears earlier in older people. The third is that no study found a point below which walking brings no benefit (Del Pozo Cruz, 2022).

For the man in the opening scene, this means the 5,000-step days are far from useless. He has already left the highest-risk band and has room to gain up to around 8,000 to 10,000, the plateau band for his age. Hitting 10,000 two days a week counts for less than raising the daily average consistently.

Intensity is an open point. In several studies, walking faster was associated with lower risk, but part of that association disappeared when the total number of steps was taken into account (Lee, 2019; Paluch, 2022). In practice, increasing the amount seems more important than speeding up the pace for those who are starting out.

Sitting time as a risk factor of its own

Sitting a lot and moving little are similar things, but not identical. A person can meet the weekly activity target and spend ten hours a day sitting. Patterson's meta-analysis gathered 34 studies with more than 1.3 million participants to separate the two effects (Patterson, 2018).

Even after adjusting for physical activity, total sitting time was associated with higher all-cause and cardiovascular mortality, with a curve that steepens above certain thresholds. Risk increased more from 6 to 8 hours of sitting per day and from 3 to 4 hours of television per day (Patterson, 2018). Sitting time was also linearly associated with type 2 diabetes.

Ekelund's accelerometer meta-analysis reached a similar conclusion with an objective measure. The quartile that sat the most had a hazard ratio for death of 2.63 compared with the quartile that sat the least (Ekelund, 2019). The WHO guideline incorporated this evidence with its own recommendation to reduce sitting time, but acknowledged that the evidence still does not allow defining an hours limit (Bull, 2020).

Breaking up sitting time and short bursts of effort

If sitting a lot is a problem, breaking up sitting time is part of the solution. The American College of Sports Medicine consensus on type 2 diabetes describes studies in which light walking breaks or simple resistance exercises, 3 minutes every 30 minutes, reduced glucose, insulin and triglycerides after meals (Kanaley, 2022). This is a recommendation that is easy to fit into the routine of people who work seated.

Another line of research looked at people who say they do not exercise. In the UK Biobank, 25,241 people who did not practice leisure-time physical activity wore an accelerometer (Stamatakis, 2022). The researchers measured short bursts of vigorous activity embedded in daily life, such as climbing stairs quickly or carrying heavy shopping, called vigorous intermittent lifestyle physical activity.

The median was three bursts per day, of 1 to 2 minutes each, and this amount was associated with lower all-cause, cardiovascular and cancer mortality compared with no bursts (Stamatakis, 2022). The association was almost linear. The authors suggest that this type of activity may be a useful target for people who cannot or do not want to do structured exercise.

For the man in the scene, these two lines offer concrete strategies: get up every half hour, take the stairs instead of the elevator, and turn short trips into brief, intense effort. These are changes that fit into the workday, without depending on the evening walk.

The limits of these studies

All these data come from observational studies. They show association, and causality requires caution. The main problem is reverse causality: sick people walk less because they are sick, and part of the mortality difference reflects disease that already existed, not a lack of steps.

The studies try to reduce this bias in various ways. They exclude deaths from the first years of follow-up and adjust for prior diseases, self-rated health and mobility limitations (Saint-Maurice, 2020). Even so, no adjustment eliminates the problem entirely, and selective recall by those reporting habits also distorts questionnaire studies, a topic close to the two memory biases. In the American study, those who took more steps were younger, had a lower body mass index, more schooling and fewer chronic diseases.

There are also measurement limits. The week of accelerometer use may not represent years of life, and wrist and waist devices count steps differently (Del Pozo Cruz, 2022). The populations studied are mostly white and from high-income countries, which limits generalization. The plateau values are approximations, not exact targets.

None of this cancels out the coherence of the findings. The step studies agree with the evidence on physical activity in general, which includes clinical trials on intermediate risk factors and a plausible biological relationship (Kraus, 2019). The balanced reading is to treat the numbers as guidance on direction and order of magnitude, not as proof that exactly 7500 steps save lives. Knowing why we get the estimate wrong helps avoid both exaggerated enthusiasm and dismissal.

How to use steps in the consultation

The step counter the patient already carries in their pocket is a ready-made measuring instrument. The first step is to know the current average, not the best day. A week of recording gives a more honest baseline than the patient's memory.

The goal should start from that baseline. For someone at 3 or 4 thousand steps, adding 1000 to 2000 steps per day is a realistic target and corresponds to the steepest part of the curve (Banach, 2023). For older adults, a goal of 6 to 8 thousand steps is supported by the plateau range, and for younger adults, 8 to 10 thousand (Paluch, 2022).

Some situations call for adjustment. In older adults at risk of falls, increasing steps without training balance can expose the person to falls, and the assessment of those who fall follows the logic of a fall from standing height. On days of extreme heat, walking during the hottest hours brings its own risks, discussed in the text on the heat illness spectrum. In people who use insulin, more activity calls for attention to the classification of hypoglycemia.

Steps do not replace the other parts of the recommendation. Strength training on two or more days per week and reducing sitting time remain necessary (Bull, 2020). And the follow-up with the step record allows the goal to be adjusted, using time as an ally, as in watchful waiting.

It is also worth avoiding excess. Turning the step counter into a source of guilt or unnecessary tests goes against the idea of quaternary prevention. The most useful message for someone sedentary is simple: any increase counts, and the biggest gain is at the start.

A script for the man in the scene

Returning to the 52-year-old patient, the conversation can follow a simple order. First, look at the week's average on the watch, not the two days the goal was met. If it is close to 5 thousand, the aim for the coming weeks is to raise that average gradually, adding short walks throughout the day instead of concentrating everything at night (Banach, 2023).

Second, tackle the hours spent sitting. He spends ten hours in the chair, above the range in which risk starts to rise more clearly (Patterson, 2018). Standing up every half hour, taking phone calls on foot and walking to a colleague's office instead of sending a message are small changes that reduce that time and add steps at the same time.

Third, make use of short bursts. Climbing the building's stairs at a faster pace, for one or two minutes, falls into the category of vigorous everyday activity that has been associated with lower mortality in people who did not exercise (Stamatakis, 2022). Finally, combine all of this with strength training on two days of the week, as the guideline calls for (Bull, 2020).

The follow-up should look at the trend of the weekly average. If it has risen, the next goal can be the plateau range for the age. If it has stayed flat, it is worth understanding why: pain, lack of time, weather, fear of falling. The concrete barrier guides the next step better than repeating the ideal number.

Common mistakes in reading the curves

The first mistake is treating the plateau as a ceiling. The curve flattens for mortality, but more activity may bring other gains, such as physical capacity and weight control, which mortality studies do not measure (Kraus, 2019). Someone who already walks 12 thousand steps a day does not need to reduce.

The second mistake is comparing step counts from different devices as if they were the same. A wrist counter records arm movements that a waist device ignores, and the plateau values came from specific devices and populations (Del Pozo Cruz, 2022). The most useful approach is to compare the patient with themselves, on the same device, over time.

The third mistake is reading the hazard ratio as an individual chance. A large relative reduction can correspond to a small absolute difference in someone with low baseline risk, and to a large difference in someone with high risk. The same caution applies to any population estimate applied to one person, just as sensitivity and predictive values change depending on who takes the test.

How NEXO helps train this reasoning

In NEXO, the case of the day is fictional, with a real clinical presentation and up to six progressive clues, and you propose the diagnosis by searching for the ICD-10 code.

The limits of using the game are described on the NEXO economy page. If you research the teaching of clinical reasoning, the page for researchers explains how to get in touch. Professionals who write or review cases find information on curation and on creators, and institutions can learn about the proposal on the partnerships page. Reading each clue as a test completes this training.

Frequently asked questions

Do I really need to take 10,000 steps a day?

The goal probably came from the name of a Japanese pedometer from 1965 (Lee, 2019). Studies show a plateau between 6000 and 8000 steps from age 60 and between 8000 and 10,000 below that age (Paluch, 2022).

Does walking a little help at all?

It does. The studies found no minimum threshold, and the biggest gain appears when leaving the lowest levels (Del Pozo Cruz, 2022).

Does walking fast matter more than walking a lot?

Speed was associated with lower risk, but much of the association disappeared after adjusting for total steps (Lee, 2019).

Can people who exercise sit the rest of the day?

Sitting time is associated with higher mortality even after adjusting for physical activity, especially above 6 to 8 hours a day (Patterson, 2018).

Do short breaks make a difference?

In people with type 2 diabetes, 3-minute breaks every 30 minutes reduced glucose after meals (Kanaley, 2022).

Do these studies prove that steps reduce mortality?

They show a strong and consistent association, but they are observational and subject to reverse causality (Saint-Maurice, 2020).

Take-home messages

• The 10,000-step goal began as a commercial brand, and the curves show a plateau before that in older adults.
• The biggest gain is when leaving the lowest step levels, and no minimum threshold was found.
• From age 60, the plateau is near 6 to 8 thousand steps; below that age, near 8 to 10 thousand.
• Sitting time carries its own weight, especially above 6 to 8 hours a day.
• Short breaks and brief bursts of effort in daily life are also associated with lower risk.
• The data are observational and indicate direction and order of magnitude, not exact targets.
• The step goal should start from the patient's current average and come together with strength and less sitting time.

Play the case of the day on NEXO.

References

1. Paluch AE, Bajpai S, Bassett DR, et al. Daily steps and all-cause mortality: a meta-analysis of 15 international cohorts. Lancet Public Health. 2022. PMID 35247352. DOI 10.1016/S2468-2667(21)00302-9.
2. Saint-Maurice PF, Troiano RP, Bassett DR Jr, et al. Association of Daily Step Count and Step Intensity With Mortality Among US Adults. JAMA. 2020. PMID 32207799. DOI 10.1001/jama.2020.1382.
3. Lee IM, Shiroma EJ, Kamada M, et al. Association of Step Volume and Intensity With All-Cause Mortality in Older Women. JAMA Intern Med. 2019. PMID 31141585. DOI 10.1001/jamainternmed.2019.0899.
4. Banach M, Lewek J, Surma S, et al. The association between daily step count and all-cause and cardiovascular mortality: a meta-analysis. Eur J Prev Cardiol. 2023. PMID 37555441. DOI 10.1093/eurjpc/zwad229.
5. Del Pozo Cruz B, Ahmadi MN, Lee IM, et al. Prospective Associations of Daily Step Counts and Intensity With Cancer and Cardiovascular Disease Incidence and Mortality and All-Cause Mortality. JAMA Intern Med. 2022. PMID 36094529. DOI 10.1001/jamainternmed.2022.4000.
6. Ekelund U, Tarp J, Steene-Johannessen J, et al. Dose-response associations between accelerometry measured physical activity and sedentary time and all cause mortality: systematic review and harmonised meta-analysis. BMJ. 2019. PMID 31434697. DOI 10.1136/bmj.l4570.
7. Patterson R, McNamara E, Tainio M, et al. Sedentary behaviour and risk of all-cause, cardiovascular and cancer mortality, and incident type 2 diabetes: a systematic review and dose response meta-analysis. Eur J Epidemiol. 2018. PMID 29589226. DOI 10.1007/s10654-018-0380-1.
8. Stamatakis E, Ahmadi MN, Gill JMR, et al. Association of wearable device-measured vigorous intermittent lifestyle physical activity with mortality. Nat Med. 2022. PMID 36482104. DOI 10.1038/s41591-022-02100-x.
9. Bull FC, Al-Ansari SS, Biddle S, et al. World Health Organization 2020 guidelines on physical activity and sedentary behaviour. Br J Sports Med. 2020. PMID 33239350. DOI 10.1136/bjsports-2020-102955.
10. Kraus WE, Powell KE, Haskell WL, et al. Physical Activity, All-Cause and Cardiovascular Mortality, and Cardiovascular Disease. Med Sci Sports Exerc. 2019. PMID 31095084. DOI 10.1249/MSS.0000000000001939.
11. Kanaley JA, Colberg SR, Corcoran MH, et al. Exercise/Physical Activity in Individuals with Type 2 Diabetes: A Consensus Statement from the American College of Sports Medicine. Med Sci Sports Exerc. 2022. PMID 35029593. DOI 10.1249/MSS.0000000000002800.